Patient education

Do I need an iron infusion?

Medically reviewed by Kelly Casteel, MD, board-certified hematologist · Updated October 21, 2026

The short answer

An iron infusion should be considered for severe iron-deficiency anemia, chronic iron deficiency with ongoing bleeding, deficiency that persists despite more than 12 weeks of oral iron, intolerance of oral iron, pregnancy beyond the first trimester, restless legs syndrome with a ferritin at or below 100 ng/mL (up to 300 ng/mL when symptoms are moderate to severe), and certain conditions such as heart failure and chronic kidney disease. No single lab number decides it — the decision combines your ferritin, transferrin saturation, hemoglobin, symptoms, and the underlying cause of the deficiency. One important 2026 change: the American Society of Hematology raised the ferritin cutoff that defines iron deficiency in adults to 30 ng/mL (50 ng/mL with symptoms or risk factors), so more people now qualify for treatment than under the old cutoff of 15.

This page is education, not medical advice — discuss your specific circumstances with your physician.

IV iron replaces your body's iron stores directly through a vein, bypassing the gut entirely. This page explains how hematologists actually decide between oral iron and IV iron — and what to expect if an infusion is right for you.

What ferritin level warrants an iron infusion?

Ferritin is the blood test that reflects your body's iron stores, and it's the starting point — but not the finish line — of the decision. In September 2026 the American Society of Hematology (ASH) published its first formal guideline on diagnosing iron deficiency, and it raised the bar. A ferritin at or below 30 ng/mL now defines iron deficiency in adults, including menstruating and pregnant people (the old cutoff was 15). A ferritin at or below 50 ng/mL is considered appropriate for people with symptoms, heavy periods, anemia in pregnancy, or other ongoing risk factors. Many lab reports still print the old "normal" range, which is why a result flagged as normal can still mean you are iron deficient. Whether a deficiency is best treated with pills or an infusion depends on everything else going on.

How ferritin is interpreted in iron deficiency (2026 ASH guideline)
Ferritin	What it usually means	Typical approach
30 ng/mL or below	Iron deficiency by the 2026 ASH definition; below 20, iron stores are essentially empty	Treatment indicated; IV iron considered per the criteria below
30–50 ng/mL	Iron deficiency when symptoms, heavy menstrual bleeding, anemia in pregnancy, or other risk factors are present	Treatment usually warranted; oral iron is a reasonable first step unless one of the IV criteria below applies
50–100 ng/mL	Depends on context — inflammation, heart failure, kidney disease, and restless legs all raise the number that counts as "low"	Specialist interpretation; iron may still be the problem even with a "normal" ferritin
Above 100 ng/mL	Iron deficiency is less likely, but not excluded	Review transferrin saturation to look for functional iron deficiency; in moderate-to-severe restless legs, IV iron is still supported up to 300 ng/mL; elevated ferritin has its own workup

Ranges are general guides for adults, not a diagnosis. Ferritin rises with inflammation, so a "normal" number can hide true deficiency — this is one of the most common reasons iron deficiency goes untreated. For anyone with an inflammatory condition (cancer, inflammatory bowel disease, chronic infection), ASH now advises checking ferritin and transferrin saturation together and considering iron deficiency when ferritin is below 100 ng/mL or TSAT is below 20%.

Transferrin saturation (TSAT) matters just as much: a TSAT below 20% supports iron deficiency even when ferritin looks acceptable. It is most reliable when drawn in the morning after several hours without food or iron supplements. If you've been told your iron is "borderline" but you feel terrible, that combination is exactly what a specialist visit is for.

The 2026 ASH guideline covers diagnosis; ASH expects to publish separate guidance on treating iron deficiency in 2027. The IV iron criteria below reflect current specialist practice and the trial evidence behind it.

When is IV iron recommended over oral iron?

Oral iron works well for many people and is usually the first step. The bottom line: IV iron should be considered in these situations:

Severe anemia due to iron deficiency. When hemoglobin is low enough that correction shouldn't wait for months of pills to work.
Chronic iron deficiency anemia with ongoing bleeding. Heavy menstrual periods and gastrointestinal blood loss can outpace what pills replace. (Managing the bleeding itself is a separate, equally important issue.)
Persistent iron deficiency despite more than 12 weeks of oral iron. This includes people whose gut can't absorb iron well — celiac disease, prior bariatric (weight-loss) surgery, inflammatory bowel disease.
Intolerance of oral iron. Nausea, constipation, or stomach pain make pills unsustainable — this is extremely common.
Pregnancy beyond the first trimester. IV iron becomes an option after the first trimester when iron deficiency needs to be corrected.
Restless legs syndrome with a ferritin at or below 100 ng/mL — or up to 300 ng/mL when symptoms are moderate to severe. The 2024 American Academy of Sleep Medicine guideline gives IV ferric carboxymaltose its strongest recommendation for restless legs, and the randomized trials behind it enrolled patients with ferritin all the way up to 300 — details below.
Other medical conditions, including heart failure and chronic kidney disease. In these conditions oral iron is often poorly absorbed and clinical trials support the IV route.

Restless legs syndrome: when "normal" iron isn't enough

Restless legs syndrome (RLS) — an irresistible urge to move your legs in the evening, often with crawling or aching sensations that ease when you move — is one of the most under-recognized consequences of low iron. The brain needs iron to make and use dopamine, and brain iron can be low even when blood counts look fine. That is why RLS uses different iron targets from the rest of medicine.

The American Academy of Sleep Medicine (AASM) rewrote its RLS treatment guideline in 2024, and iron is now central to it:

Everyone with meaningful RLS should have ferritin and transferrin saturation checked, ideally in the morning after avoiding iron supplements and iron-rich foods for 24 hours.
Ferritin at or below 75 ng/mL, or TSAT below 20%: iron treatment is advised, by mouth or by vein.
Ferritin between 75 and 100 ng/mL: IV iron specifically, because oral iron rarely raises ferritin enough at that level.
IV ferric carboxymaltose received the guideline's strongest recommendation of any RLS treatment, based on multiple randomized trials. Two other IV formulations (low-molecular-weight iron dextran and ferumoxytol) and oral ferrous sulfate are also supported. For people on dialysis, IV iron sucrose is suggested when ferritin is below 200 ng/mL and TSAT is below 20%.
The old first-line drugs are no longer first-line. Dopamine agonists such as pramipexole and ropinirole are now recommended against for routine use, because long-term use can make RLS worse over time (a problem called augmentation). Iron and gabapentin-type medicines are preferred.

In practical terms: if you have restless legs and a ferritin of 60, your lab report will say "normal," the sleep guideline says treat, and the evidence favors IV iron. Improvement after an infusion typically appears over several weeks rather than days, and some people need a repeat infusion months later as ferritin drifts back down.

Moderate-to-severe RLS with a ferritin up to 300: what the evidence shows

The 75-and-100 cutoffs above are consensus numbers. The actual clinical trials of IV iron in restless legs went considerably higher. The International Restless Legs Syndrome Study Group's 2018 evidence-based guideline rated IV ferric carboxymaltose 1,000 mg as Level A evidence (the highest grade) for moderate-to-severe RLS in adults with a ferritin below 300 ng/mL and transferrin saturation below 45%, and stated it could be used as first-line treatment. It also allows repeat infusions, at least 12 weeks apart, as long as ferritin stays below 300 and TSAT below 45%. The 2024 AASM guideline's strong recommendation rests on the same trials.

Key studies of IV ferric carboxymaltose in moderate-to-severe RLS
Study	Who was treated	What happened
Allen 2011 Randomized, placebo-controlled, 46 patients	Moderate-to-severe RLS, 1,000 mg FCM; enrollment was not limited to low ferritin	RLS severity score fell 8.9 points vs 4.0 on placebo; 48% "much improved" vs 14%; 1 in 4 still needed no RLS medication 24 weeks later
Cho 2016 Randomized, placebo-controlled, non-anemic patients	Moderate-to-severe RLS without anemia, single 1,000 mg FCM	Severity score fell 11.9 vs 7.9 on placebo; 59% responded; 38% were still medication-free at 30 weeks
Earley 2024 Randomized, placebo-controlled, 209 patients	Moderate-to-severe RLS with ferritin below 300 and TSAT below 45% as the only iron criteria; 1,500 mg FCM	Severity score fell 8.0 vs 4.8 on placebo; only 33% needed rescue RLS medication vs 59%. Temporary low phosphate was common.
Garcia-Malo 2025 58 patients, ferritin under 100 vs 100–300	RLS treated with 1,000 mg FCM, grouped by whether baseline ferritin was below or above 100	Both groups improved the same amount, including brain-iron changes on ultrasound. Only 2 patients briefly exceeded a TSAT of 45%, with no harm.

FCM = ferric carboxymaltose (Injectafer). Severity is the International RLS Severity Scale (0–40); a drop of 6 or more points is generally considered clinically meaningful. A 2024 meta-analysis of all 7 randomized trials (537 patients) confirmed the benefit.

The takeaway: if your restless legs are moderate to severe and your ferritin is anywhere under 300, a "normal" ferritin is not a reason to withhold IV iron. The safety guardrail is transferrin saturation: we confirm it is below 45% (and, when the picture suggests it, rule out hereditary hemochromatosis) before infusing iron at a ferritin that is already in the normal range. Lower TSAT also predicts a better response.

Is IV iron safe?

Modern IV iron is much safer than its reputation. The serious allergic reactions people worry about were largely a problem of an older formulation (high-molecular-weight iron dextran) that is no longer used. With current formulations, severe reactions are rare, and infusions are given in a monitored setting specifically so that any reaction can be treated immediately.

What patients actually experience, occasionally: temporary flushing or pressure in the chest or back during the infusion (which settles when the rate is slowed), and headache, nausea, or achiness for a day or two afterward. Two things worth knowing about specific formulations: some can cause temporary drops in blood phosphate, and leakage at the IV site can rarely cause a long-lasting skin stain — both are reasons infusions belong in experienced hands.

If you'd like the deeper history — including how the field moved from risky early formulations to today's single-visit products — I maintain an interactive timeline of iron treatments covering the pivotal trials and safety data behind each one.

What happens at an iron infusion appointment?

At Rocky Mountain Cancer Centers in Longmont, infusions happen on-site. A nurse places a small IV, the iron is given, and you're observed briefly afterward. Most people drive themselves home and go about their day. How long each infusion takes and how many visits you'll need depend strongly on which product is used — your care team will map out the plan for your specific formulation.

How fast will I feel better?

Your iron stores are replenished the day of the infusion, but your body needs time to put that iron to work. Most patients notice energy improving over two to four weeks. If you're anemic, hemoglobin typically recovers over four to eight weeks. Symptoms like restless legs, brain fog, and hair changes can take longer — hair in particular lags months behind the labs.

When are iron pills still the right choice?

Often. If your deficiency is mild, your gut absorbs iron normally, and the cause has been addressed, oral iron is effective, inexpensive, and reasonable to try first. Two evidence-based tips that improve success: taking iron every other day rather than daily actually improves absorption and reduces side effects, and pairing it with vitamin C (or simply taking it on an empty stomach) helps. If 12 weeks (three months) of properly-taken oral iron hasn't moved your numbers, that itself is useful information — and a reason to look deeper rather than simply trying a different pill.

One caution from clinical practice: getting iron without finding out why you're deficient can mask an important underlying problem. Part of a specialist evaluation is making sure the cause — blood loss, absorption, demand — is identified, not just the number corrected.

Guidelines referenced on this page

Powers JM, Lim MY, Achebe MO, et al. American Society of Hematology 2026 guidelines for diagnosis of iron deficiency. Blood Advances. Published online September 16, 2026. doi:10.1182/bloodadvances.2025015950
Winkelman JW, Berkowski JA, DelRosso LM, et al. Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2025;21(1). doi:10.5664/jcsm.11390
Allen RP, Picchietti DL, Auerbach M, et al. Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. Sleep Medicine. 2018;41:27–44. doi:10.1016/j.sleep.2017.11.1126
Allen RP, Adler CH, Du W, et al. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial. Sleep Medicine. 2011;12(9):906–913. doi:10.1016/j.sleep.2011.06.009
Cho YW, Allen RP, Earley CJ. Clinical efficacy of ferric carboxymaltose treatment in patients with restless legs syndrome. Sleep Medicine. 2016;25:16–23. doi:10.1016/j.sleep.2016.06.021
Earley CJ, García-Borreguero D, Falone M, Winkelman JW. Clinical efficacy and safety of intravenous ferric carboxymaltose for treatment of restless legs syndrome: a multicenter, randomized, placebo-controlled clinical trial. Sleep. 2024;47(7):zsae095. doi:10.1093/sleep/zsae095
Garcia-Malo C, Garcia-Borreguero D, Silber MH. Efficacy and safety of intravenous iron in patients with restless legs syndrome with normal serum ferritin levels: a stratified subanalysis. Journal of Clinical Sleep Medicine. 2025;21(12):2023–2029. doi:10.5664/jcsm.11846
Qadri SN, Jamil S, Zahid S, et al. Clinical efficacy and safety of IV ferric carboxymaltose in restless legs syndrome: a meta-analysis of 537 patients. Sleep Medicine. 2024;124:244–253. doi:10.1016/j.sleep.2024.09.017

Wondering whether IV iron is right for you?

Dr. Casteel evaluates iron deficiency and performs IV iron infusion on-site at Rocky Mountain Cancer Centers in Longmont, serving the northern Front Range. Virtual visits are available throughout Colorado.

Request an appointment Call (303) 684-1900

Iron infusion questions, answered

How long does an iron infusion take?

It depends strongly on which product is used. Some formulations are given in a single visit; others are dosed as a series of shorter infusions. Your care team will tell you the expected time and number of visits for the specific product prescribed. Plan for extra time at the first visit for check-in and a brief observation period.

How quickly will I feel better after an iron infusion?

Iron stores are replenished immediately, but the body needs time to use that iron. Many patients notice energy improving over two to four weeks. When anemia is present, hemoglobin typically rises over four to eight weeks. Symptoms like restless legs or brain fog can lag behind the blood counts.

What are the side effects of IV iron?

Modern IV iron formulations are well tolerated. The most common effects are mild: temporary headache, nausea, muscle aches, or a flushing reaction during the infusion that resolves when the rate is slowed. Severe allergic reactions are rare with current formulations, and infusions are given with monitoring for exactly that reason. Certain formulations can temporarily lower phosphate levels, which is one reason specialist follow-up matters.

Does insurance cover iron infusions?

Usually yes, when there is a documented medical indication such as iron deficiency anemia or iron deficiency that has not responded to oral iron. Coverage details vary by plan and by formulation, and some plans require prior authorization. The office handles prior authorization when needed.

What is the new ferritin cutoff for iron deficiency?

The American Society of Hematology's 2026 guideline defines iron deficiency in adults, including menstruating and pregnant people, as a ferritin at or below 30 ng/mL, up from the long-used 15 ng/mL. A cutoff of 50 ng/mL is considered appropriate when there are symptoms, heavy menstrual bleeding, anemia in pregnancy, or other ongoing risk factors. In people with inflammatory conditions, iron deficiency is considered when ferritin is below 100 ng/mL or transferrin saturation is below 20%.

Can an iron infusion help restless legs syndrome?

Yes, for many people. The 2024 American Academy of Sleep Medicine guideline recommends checking ferritin and transferrin saturation in everyone with significant restless legs, treating with iron when ferritin is 75 ng/mL or below or TSAT is below 20%, and using IV iron specifically when ferritin is between 75 and 100 ng/mL. IV ferric carboxymaltose received the guideline's strongest recommendation. For moderate-to-severe RLS, the trials behind that recommendation enrolled patients with ferritin up to 300 ng/mL (with transferrin saturation below 45%), and the International RLS Study Group rates IV iron as Level A evidence across that whole range. Improvement usually appears over several weeks, not days.

Can I get an iron infusion without seeing a specialist?

Some primary care and GI practices arrange IV iron directly. A specialist visit adds value when the diagnosis is unclear, when deficiency keeps coming back, or when the cause of iron loss has not been identified — because giving iron without finding the cause can hide an important underlying problem.

About the author

Kelly Casteel, MD is board certified in hematology and medical oncology. She trained at MD Anderson Cancer Center and practices at Rocky Mountain Cancer Centers in Longmont, Colorado, where her clinical focus includes iron deficiency, iron deficiency anemia, and hereditary hemochromatosis. She performs IV iron infusion and therapeutic phlebotomy on-site.

More about Dr. Casteel · Schedule a visit